Claim this page free
AI visibility score
2.58/ 10Near-invisible

▼ 0.02 since Nov 2026

Top 25% in Healthcare

As of 2026-11-09 · Engagemii Index

AI Visibility Scorecard

Oncotype DX Breast Recurrence Score® Test for Patients

Oncotype DX Breast Recurrence Score® Test for Patients

Unclaimed

geneticsvsgenomics.com · Healthcare

At 2.58/10, Oncotype DX Breast Recurrence Score® Test for Patients is near-invisible in AI search today. Most AI engines will not name it when asked about its category. The weakest signals are Structured Data, E-E-A-T Signals and Backlinks. That is fixable, and the signals below show where to start.

AI engines read this profile 10 times

Meta AI · Claude · Apple Intelligence

Top 25% in Healthcare for AI visibility

20

AI Naming Predictability

i

Rarely named · 20/100

Healthcare average 11

Top 19% of Healthcare

See what's behind this score →

2.58

AEO Visibility

i

Near-invisible · 2.58/10

Healthcare average 2.3

See what's behind this score →

-

Network Authority

i

Not connected yet

0 relationships on record. Businesses in Healthcare average 3. Claim your page and Engagemii is your first.

See what's behind this score →

0

Muse Index Score

i

AI agent readiness

Not agent-ready · 0/100

Healthcare average 18

See what's behind this score →

0

AI Adoption

i

None detected · 0/100

Healthcare average 0

See what's behind this score →

Share

About Oncotype DX Breast Recurrence Score® Test for Patients

from our crawl and measurement

Oncotype DX Breast Recurrence Score® Test for Patients, based in Madison, WI, describes itself simply: "The Oncotype DX Breast Recurrence Score Test helps determine distant recurrence and is predictive of chemotherapy benefit." To AI engines like ChatGPT and Perplexity, though, it is barely visible: it scores 2.58 out of 10.

Our crawl found a readable heading structure. It is missing structured data describing the business, an llms.txt file and a sitemap.

AI crawlers have read this profile 10 times in our tracking, including Meta AI, ClaudeBot (Anthropic) and Applebot (Siri).

Company ·
Oncotype DX Breast Recurrence Score® Test for Patients
Industry ·
Healthcare
Location ·
Madison, WI
Site status ·
Live (The website showed an active business site when last checked (Oct 31, 2026).)
Last scored ·
Nov 9, 2026

The 6 on-page signals AI reads

Strong · Good · Fair · Weak

Structured Data

Weak

Organization / LocalBusiness JSON-LD that AI can read.

Content Structure

Strong

Clear headings and answer-style content.

Entity Clarity

Strong

How clearly your brand identity reads to AI.

E-E-A-T Signals

Experience, Expertise, Authority, Trust

Weak

Experience, Expertise, Authority, Trust markers.

Technical AEO

Fair

robots.txt, llms.txt, and AI-bot crawl access.

AI Discoverability

Strong

Sitemaps and entity links AI can follow.

The 6 off-page signals AI reads

How the web signals your brand to AI

Backlinks

Weak

No inbound links found yet.

Domain Authority

Weak

Little domain authority yet.

Reference Presence

-

Not yet measured.

News & Press

Weak

No press coverage found yet.

Community

Weak

No community discussion yet.

Social Mentions

Weak

No social discussion found yet.

What this score means

Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can read your site and name it in answers. At 2.58/10, Oncotype DX Breast Recurrence Score® Test for Patients is near-invisible to AI engines today. That is fixable, and the signals above are where to start.

Frequently Asked Questions

How likely is my cancer to come back? Will chemotherapy help?

Every patient is different and so is every tumor. The Breast Recurrence Score test uses The study of the complete set of DNA (including all of its genes) in a person or other organism.genomic information to give you and your doctor important risk information about how your individual tumor will likely behave.

Is this test right for me?

If you’ve been diagnosed with HR+, HER2- invasive breast cancer, the Oncotype DX Breast Recurrence Score test may offer you valuable insights to help guide your treatment decisions.

What happens once your doctor orders your test?

Your Breast Recurrence Score test is performed on tumor tissue that’s already been removed from your breast during your biopsy or at the time of surgery.

Picked for Oncotype DX Breast Recurrence Score® Test for Patients: AEO & AI Search

Why your brand doesn't show up in ChatGPT answers (and how to fix it)

ChatGPT doesn't crawl the web like Google does. When someone asks Claude about the best project management tools, the model isn't searching your website in real-time. It's pulling from training data that stopped months or years ago.

Continue reading in your free Engagemii portal

Sign up free to read the full article and get your AEO fix list for Oncotype DX Breast Recurrence Score® Test for Patients.

Source & Attribution

Scored by Engagemii on November 9, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/geneticsvsgenomics

Cite this score: Engagemii (2026). "AEO Score for Oncotype DX Breast Recurrence Score® Test for Patients." Retrieved from https://engagemii.com/aeo/brands/geneticsvsgenomics

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.

Powered by Engagemii - The Answer Engine Optimization (AEO) Platform